These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6595401)

  • 1. Drugs: guide and caveats to explanatory and descriptive approaches--II. Drugs in psychiatric research.
    Bollini P; Cotecchia S; De Blasi A; Romandini S; Tognoni G
    J Psychiatr Res; 1984; 18(4):391-400. PubMed ID: 6595401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic monitoring of antidepressant drugs].
    Charlier C; Ansseau M; Pinto E; Andrien F; Plomteux G
    Ann Biol Clin (Paris); 1999; 57(4):463-8. PubMed ID: 10432370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What conditions are necessary to assess antidepressant efficacy?
    Quitkin FM; Klein DF
    Arch Gen Psychiatry; 2000 Apr; 57(4):323-4. PubMed ID: 10768690
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel approaches to drug-placebo difference calculation: evidence from short-term antidepressant drug-trials.
    Rihmer Z; Gonda X; Döme P; Erdős P; Ormos M; Pani L
    Hum Psychopharmacol; 2011; 26(4-5):307-12. PubMed ID: 21755539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of depressive illness: the importance of chronic drug treatment.
    Mitchell PJ; Redfern PH
    Curr Pharm Des; 2005; 11(2):171-203. PubMed ID: 15638757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on multicenter trials of antidepressant drugs.
    Hippius H; Matussek N
    Mod Probl Pharmacopsychiatry; 1981; 16():95-100. PubMed ID: 7322137
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.
    Khan A; Warner HA; Brown WA
    Arch Gen Psychiatry; 2000 Apr; 57(4):311-7. PubMed ID: 10768687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety.
    Prus AJ; Porter JH
    Curr Top Behav Neurosci; 2018; 39():213-241. PubMed ID: 27352389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The persistence of the placebo response in antidepressant clinical trials.
    Khan A; Redding N; Brown WA
    J Psychiatr Res; 2008 Aug; 42(10):791-6. PubMed ID: 18036616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are antidepressants overrated? A review of methodological problems in antidepressant trials.
    Moncrieff J
    J Nerv Ment Dis; 2001 May; 189(5):288-95. PubMed ID: 11379971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.
    Dowrick CF; Hughes JG; Hiscock JJ; Wigglesworth M; Walley TJ
    BMC Health Serv Res; 2007 Apr; 7():64. PubMed ID: 17470280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant drug studies in the elderly.
    Rockwell E; Lam RW; Zisook S
    Psychiatr Clin North Am; 1988 Mar; 11(1):215-33. PubMed ID: 2898134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of depression in medical patients.
    Fava GA; Sonino N; Wise TN
    Psychother Psychosom; 1988; 49(2):81-102. PubMed ID: 3064121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The placebo problem remains.
    Michels KB
    Arch Gen Psychiatry; 2000 Apr; 57(4):321-2. PubMed ID: 10768689
    [No Abstract]   [Full Text] [Related]  

  • 16. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses.
    Stassen HH; Angst J; Delini-Stula A
    Pharmacopsychiatry; 1996 May; 29(3):87-96. PubMed ID: 8738312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacological action of rubidium chloride in depression].
    Brundusino AO; Cairoli S
    Minerva Psichiatr; 1996 Mar; 37(1):45-9. PubMed ID: 8926857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline characteristics of 10-day placebo washout responders in antidepressant trials.
    Rabkin JG; Stewart JW; McGrath PJ; Markowitz JS; Harrison W; Quitkin FM
    Psychiatry Res; 1987 May; 21(1):9-22. PubMed ID: 3299437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.